INTRODUCTION
Ectopic pregnancy constitutes approximately 2% of all pregnancies. It is one of the main causes of maternal mortality and morbidity in the first trimester. 1 Tubal ectopic pregnancy is the most common type of ectopic pregnancy and is responsible for 95% of cases. Cervical ectopic pregnancies (CEP) are uncommon varient, on the other hand, make up 0.2% of all ectopic pregnancy cases. 2 The reported incidence of CEP is 1 in 1000-95000 pregnancies. 3 The etiology is unknown in most cases. Patients with this variant of ectopic gestations are at a high risk of potentially life-threatening haemorrhage. Before 1980, the diagnosis commonly was made when dilation and curettage for presumed incomplete abortion resulted in unexpected haemorrhage necessitating hysterectomy. Diagnosis and treatment of cervical ectopic pregnancy has changed dramatically in the last 2 decades. Transvaginal ultrasonography (USG) and Doppler study are the recommended diagnostic tools for CEPs. 4 With the improved access to USG facilities and the rapid assay of serum human chorionic gonadotropin (HCG), the trend of modern clinical practice is rather destinated to conservative management consisting of medical and interventional measures hence preserving the fertility.
In this article we present our clinical experience with varied clinical presentations of CEP and management options. We have reviewed the literature on the probable Department of Obstetrics and Gynaecology, Mysore Medical College and Research Institute, Mysore, Karnataka 570001, India
METHODS
The retrospective study was conducted at Mysore medical college and research institute in the department of obstetrics and gynaecology. All the data were collected by reviewing the medical records on CEP cases managed at this tertiary care institute from July 2005 to June 2015. The study was approved by the institute review and ethical committee. In this study period three cases of CEP were detected. In all the cases clinical data were collected on age, parity, gestational age at diagnosis, HCG value, presence of fetal heart rate, clinical presentation, diagnosis method, management. Also data were collected on prior obstetric details as history of prior dilatation and curettage, history of prior caesarean section. Records were searched regarding total number of ectopic pregnancies managed, deliveries conducted in this period. On line literature search was done to collect all the relevant publications on CEP.
RESULTS
In this study period a total of 307 ectopic pregnancies were diagnosed at the institute. Total numbers of live births were 1, 32, 752 and three cases of CEPs were diagnosed in this study period. The incidence of CEP in our institute is 0.9% of ectopic pregnancies and 0.002% or 1in 44,250 of all livebirths. The demographic characteristics of the patients are presented in Table 1 . In the third case the patient presented in stable condition with 2 months amenorrhoea and minimal vaginal bleeding. On pelvic examination cervix was ballooned out, soft and bulky. Confirmation of CEP was made by pelvic ultrasonography (USG) which revealed live gestation of 7-8weeks with good fetal heart beat (FHB) also implantation of placenta in anterior wall of cervix. Uterine cavity was empty and internal os was closed (Figure 1, 2) . Quantitative βHCG was 85860 miu/ml at presentation. In an attempt to preserve the fertility conservative management was decided. Her haemoglobin and biochemical parameters were normal. She received systemic intramuscular methotrexate 1mg/kg. Along with this oral mefiprestone 200mg was also given in view of high βHCG and live gestation. On day 4 repeat USG showed absent FHB, absence of colour Doppler uptake and βHCG had fallen to 56240miu/ml. On day 6 she complained of spontaneous expulsion of fleshy mass and massive bleeding PV. She was shifted to emergency operation theatre, bleeding was controlled after gentle curettage followed by balloon tamponade with foley's bulb. Her serial βHCG values showed downward trend and follow up USG showed normal cervical canal.
DISCUSSION

Historical review and epidemiology of cervical pregnancy
Cervical pregnancy is defined as the implantation of the conceptus below the level of the internal os. The first case of CEP was described in 1817. The reported incidence is highest in Japan lies between one in 978 live births and it is one in 56730 in the USA. 2, 5, 6 In 1911 Rubin et al established the pathological diagnostic criteria for CEP: a) Cervical glands must be opposite the placental attachment. b) Placental attachment to the cervix must be situated below the entrance of the uterine vessels or below the peritoneal reflection of the anterior and posterior surfaces of the uterus. c) Fetal elements must be absent from the corpus uteri.
Traditionally the diagnosis of cervical pregnancy was based solely on clinical findings and histology reports after hysterectomy or clinical diagnosis of cervical pregnancy was usually made when curettage for presumed incomplete spontaneous abortion resulted in uncontrollable haemorrhage and most women required emergent hysterectomy. 7, 8 Until 1953, the reported mortality for women with cervical pregnancy was 45%.
6,7,9 Two of our cases had similar presentation which required emergency hysterectomy. With the advent of newer diagnostic and therapeutic modalities hysterectomy and mortality rates have drastically comedown in the recent years.
Etiology
The etiology of CEP is still unclear. The proposed theories are: a) Transport of the fertilized ovum might be too rapid for the possibly immature endometrium to accept it. 10 Burg et al 10 also considered the condition of fertilization in the cervix with subsequent implantation in the cervical canal, a theory that could be supported by Connor et al, who reported a pregnancy implanting at the stump of the cervix after supracervical amputation of the uterus. 11 b) Damage to the cervix and endometrial lining during operative uterine procedures. 7, 12 The most common risk factor is dilatation and curettage (69%), followed by previous caesarean delivery (35%). 13 Other risk factors include Asherman's syndrome, intrauterine devices, tumours and anomalies of reproductive tract. 5, 14 One patient in our study had curettage and prior caesarean history. c) Invitro fertilization and embryo transfer (IVF-ET) : Recently CEPs have been increasingly reported with assisted reproductive techniques including both intrauterine and intrafallopian tube embryo transfers. [15] [16] [17] [18] [19] [20] [21] d) However, it has to be stated that the absolute risk remains rather small, because these factors are common but cervical pregnancy is rare.
Clinical presentation and diagnosis
The most common symptoms of cervical pregnancy are vaginal bleeding (91%) and cramping pain (28%). Early stage asymptomatic (6%) cervical pregnancies may also be detected in routine ultrasonography. 22, 23 Clinical signs which suggest cervical pregnancy include a soft cervix that is enlarged in barrel shape, a partially open or closed external os, and profuse hemorrhage on manipulation of the cervix. A visible cervical lesion, often described as blue or purple and edematous in appearance, may be noted. 24, 25 All our cases presented with similar symptoms as vaginal bleeding (100%), pain (100%) and third case had typical clinical signs of CEP. All these dictate the need of high index of clinical suspicion of CEP as women commonly present with similar complaints.
The diagnosis of early cervical pregnancy is now possible by transvaginal ultrasonography and serum βHCG determination. Early diagnosis of CEP is essential because this will decrease the occurence of acute complications and allow the preparation and implementation of a conservative approach. The first report of a cervical ectopic pregnancy diagnosed using ultrasound was in 1978 by Raskin. 26, 27 In 1993, TimorTritsch et al proposed more stringent criteria. 28 the placenta and entire chorionic sac containing the live pregnancy must be below the internal os and the cervical canal must be dilated and barrel shaped. 29 Diagnosis of cervical pregnancy is established by visualization of an intracervical ectopic gestational sac or trophoblastic mass. Ushakov et al suggested that visualization of an intact part of the cervical canal between the endometrium and gestational sac reflects an intracervical placentation. Table 2 presents USG criteria for diagnosis of CEP. Routine use of magnetic resonance imaging is not indicated for diagnosis of CEP.
Early cervical pregnancy may be mistaken for the cervical abortion. The larger or globular uterus, absence of FHB compared to the hourglass configuration in cervical pregnancy which is often accompanied with FHB are particularly helpful.
22,29-33 Jurkovic et al described 'sliding sign' on transvaginal USG which occurs when the gestational sac of an abortus slides against the endocervical canal following gentle pressure by the sonographer and which will not be seen in an implanted cervical pregnancy may also assist in the differentiation. 8 Benson and Doubilet disputed the usefulness of colour Doppler, stating the overlap of findings between miscarriage and cervical ectopic pregnancy was too great to add significant diagnostic information. Differentiation of a true cervical pregnancy from an isthmicocervical pregnancy is important and requires demonstration of a closed internal os and sac should be below the level uterine artery insertion in USG.
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Management of cervical pregnancy
With the recent advances in early diagnosis of CEP spectrum of conservative mode of treatment has become primary first line approach enabling preservation of fertility. In majority of reported cases more than one method were combined in the management.
Medical therapy
This should be the first step in conservative therapy when the diagnosis is made early in unruptured state and patient is hemodynamically stable. Methotrexate (MTX) is the most commonly used and well tested chemotherapeutic agent in medical management of ectopic pregnancy including CEP. 8 53 Since then, several cases have been reported in literature. Variable-dose, single-dose, low-dose, and high dose MTX regimens have been reported for cervical pregnancies (Table 3) . Direct injection into the conceptus has also been investigated. 13, 27, 35, 40, 41, 51 Because the use of methotrexate in CEP is relatively new, a standardized protocol is not yet available, even for tubal pregnancy. (MTX -methotrexate, FHR-fetal heart rate, UAE-uterine artery embolization, N-number, HCG -human chorionic gonadotropin)
The success rate of exclusive administration of MTX has been reported to be as high as 81.3%, while the percentage is increased to 90% when MTX is combined with additional conservative methods. 55 According to Hung et al, failure of single MTX chemotherapy is likely if the gestational age is ≥9 weeks, fetal viability is documented, serum HCG titer is ≥10,000 milli-International Units/mL, or fetal CRL is greater than 10mm. 56 Hung et al also reported that concomitant feticide would enhance the therapeutic effect of MTX and administration of high dose MTX was not more effective than low dose MTX. 56 Ben Hamouda et al and Api et al have reported that exclusively single-dose intramuscular administration of MTX may be effective in treating cervical pregnancy without additional need for curettage. 57, 58 Feticide by local therapy consists of sonographically guided injection of medications, either intra-amniotic or intra-fetal. The most commonly reported medications are MTX and KCl. 13, 21, 27, 35, 41, 44, 46, 51 Administration of intraamniotic prostaglandins F2α have also been described by Spitzer et al and Vega et al. 59, 60 Mefiprestone administered along with MTX to induce feticide has been reported by Pathak et al and Shreshta et al. 43, 48 In the presence of progesterone, mifepristone acts as a competitive receptor antagonist at the progesterone receptor. Mifepristone induces decidual breakdown indirectly, leading to trophoblast detachment and resulting in decreased syncytiotrophoblast production of HCG, which in turn causes decreased production of progesterone by the corpus luteum. The combination of these two drugs will prevent the development of embryos and speed up embryonic death, which will definitely shorten the treatment time. The advantages of combining mefiprestone are easy oral route of administration, reduction in the dose of MTX and reduced MTX failure rate.
In our third case also same benefits were obtained by using mefiprestone. Hence, we could employ single low dose MTX even in the presence of high HCG titre. Administration of mefiprestone was easier compared to technical difficulties and risk of bleeding which may follow local KCL/MTX injection.
Minimally invasive surgical procedures
These procedures aim at removal of trophoblastic tissue and often follow the medical therapy as second line of treatment of CEP. These include curettage, aspiration, hysteroscopic endocervical resection, cervical amputation. 12 This approach can cause haemorrhage requiring additional methods to reduce blood loss.
Procedures to reduce haemorrhage
Procedures to reduce blood supply to CEP can be used as third step approach of management if active bleeding is encountered during excision of cervical pregnancy when MTX proves unsuccessful. This can also be clubbed as secondary approach in preparation for surgical therapy like curettage or in combination with chemotherapy. The methods include intracervical ballon tamponade, cervical cerclage (shirhodkars), vaginal ligation of cervical arteries, uterine artery ligation, internal ileac artery ligation and angiographic embolozation of uterine or internal ileac arteries. [36] [37] [38] 41, 45, 51 Selective uterine arterial embolization (UAE) has become accepted as a highly effective technique for controlling acute or chronic genital bleeding. UAE is optimally employed prior to internal iliac artery ligation or hysterectomy and has various therapeutic advantages, such as avoidance of surgical risks and preservation of fertility. 24, 30, 49 Although relatively safe UAE complications like uterine infarction, bladder necrosis have been documented. Hwang et al 61 and Hsieh et al 62 recommended vasopressin injection for cervical hemorrhage after local MTX. In our third case foley's balloon tamponade was employed to reduce bleeding.
Hysterectomy
If bleeding cannot be controlled by conservative measures, hysterectomy which is a radical approach should be performed as lifesaving measure. Primary hysterectomy may still prove to be appropriate in settings of intractable haemorrhage, second or third-trimester diagnosis of cervical pregnancy and possibly to avoid emergency surgery in a woman who does not desire fertility. 23, 50, 52 The first two of our cases developed torrential bleeding which forced us to resort to hysterectomy as lifesaving measure.
Subsequent fertility after CEP
The fundamental principle of adopting the tedious conservative approach in CEP management is the immense concern in preserving the future childbearing potential. MTX, a cytotoxic drug, has been thought to have a potential mutagenic activity on human gamete and also teratogenic effect on the conceptus. Actually, total doses of MTX used during the entire treatment course of cervical pregnancy were not high when compared with those used for treating gestational trophoblastic tumours. 63 According to this observation, patients experiencing MTX administration are not likely to be at increased risk of fetal anomalies or spontaneous abortion in later conceptions. Also, it appears that when a sufficient portion of the cervix is preserved, cervical function is more likely to recover. According to studies by Kung et al and Jeng et al a prior cervical pregnancy with MTX treatment does not impair subsequent reproductive function and that the risk of infertility after MTX therapy does not generally increase. 41, 63 Still, these patients may be adviced contraception for 6 months to minimize potential teratogenic risks. Early USG is indicated in subsequent pregnancy to rule out recurrence of ectopic pregnancy. Pregnancy should be watched for possible complications like cervical incompitance or preterm labour.
Several reports of successful continuation of intrauterine pregnancy after local interventions to terminate CEP in cases of heterotopic pregnancies are available. 20, 21 It is prudent to watch for heterotopic pregnancies in conceptions following IVF and ET.
